Related references
Note: Only part of the references are listed.Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
Fernanda G. Herrera et al.
CANCER DISCOVERY (2022)
The CXCL11-CXCR3A axis influences the infiltration of CD274 and IDO1 in oral squamous cell carcinoma
Xin Wang et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2021)
High indoleamine-2,3-dioxygenase 1 (IDO) activity is linked to primary resistance to immunotherapy in non-small cell lung cancer (NSCLC)
Florian Kocher et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2021)
Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma
Tatenda Mahlokozera et al.
NATURE COMMUNICATIONS (2021)
UCSC Cell Browser: visualize your single-cell data
Matthew L. Speir et al.
BIOINFORMATICS (2021)
Tryptophan metabolism in brain tumors-IDO and beyond
Michael Platten et al.
CURRENT OPINION IN IMMUNOLOGY (2021)
Macrophages/Microglia Represent the Major Source of Indolamine 2,3-Dioxygenase Expression in Melanoma Metastases of the Brain
Dayana Herrera-Rios et al.
FRONTIERS IN IMMUNOLOGY (2020)
Human GBP1 binds LPS to initiate assembly of a caspase-4 activating platform on cytosolic bacteria
Jose Carlos Santos et al.
NATURE COMMUNICATIONS (2020)
Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy
Maria Georganaki et al.
ONCOIMMUNOLOGY (2020)
Immunotherapy in CNS cancers: the role of immune cell trafficking
Nivedita M. Ratnam et al.
NEURO-ONCOLOGY (2019)
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
Michael Platten et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors
Denarda Dangaj et al.
CANCER CELL (2019)
Limitations and Off-Target Effects of Tryptophan-Related IDO Inhibitors in Cancer Treatment
Juliane Guenther et al.
FRONTIERS IN IMMUNOLOGY (2019)
Metabolomic adaptations and correlates of survival to immune checkpoint blockade
Haoxin Li et al.
NATURE COMMUNICATIONS (2019)
Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan-Kynurenine-Aryl Hydrocarbon Axis
Brian W. Labadie et al.
CLINICAL CANCER RESEARCH (2019)
Local Irradiation Sensitized Tumors to Adoptive T Cell Therapy via Enhancing the Cross-Priming, Homing, and Cytotoxicity of Antigen-Specific CD8 T Cells
Jin-Zhi Lai et al.
FRONTIERS IN IMMUNOLOGY (2019)
An effective mouse model for adoptive cancer immunotherapy targeting neoantigens
Ken-ichi Hanada et al.
JCI INSIGHT (2019)
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy
Ryuma Tokunaga et al.
CANCER TREATMENT REVIEWS (2018)
IDO1 in cancer: a Gemini of immune checkpoints
Lijie Zhai et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2018)
Tryptophan Metabolism Contributes to Radiation-Induced Immune Checkpoint Reactivation in Glioblastoma
Pravin Kesarwani et al.
CLINICAL CANCER RESEARCH (2018)
ISG15 in antiviral immunity and beyond
Yi-Chieh Perng et al.
NATURE REVIEWS MICROBIOLOGY (2018)
NKG2D-Based CAR T Cells and Radiotherapy Exert Synergistic Efficacy in Glioblastoma
Tobias Weiss et al.
CANCER RESEARCH (2018)
IFN-γ promotes transendothelial migration of CD4+ T cells across the blood-brain barrier
Sandip Ashok Sonar et al.
IMMUNOLOGY AND CELL BIOLOGY (2017)
Single-Cell RNA-Seq Analysis of Infiltrating Neoplastic Cells at the Migrating Front of Human Glioblastoma
Spyros Darmanis et al.
CELL REPORTS (2017)
Infiltrating T Cells Increase IDO1 Expression in Glioblastoma and Contribute to Decreased Patient Survival
Lijie Zhai et al.
CLINICAL CANCER RESEARCH (2017)
Non-tumor cell IDO1 predominantly contributes to enzyme activity and response to CTLA-4/PD-L1 inhibition in mouse glioblastoma
Lijie Zhai et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
The Microenvironmental Landscape of Brain Tumors
Daniela F. Quail et al.
CANCER CELL (2017)
Tryptophan-2,3-dioxygenase is regulated by prostaglandin E2 in malignant glioma via a positive signaling loop involving prostaglandin E receptor-4
Katharina Ochs et al.
JOURNAL OF NEUROCHEMISTRY (2016)
IDO1 is an Integral Mediator of Inflammatory Neovascularization
Arpita Mondal et al.
EBIOMEDICINE (2016)
Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats
M. J. Walters et al.
BRITISH JOURNAL OF CANCER (2014)
Immature mesenchymal stem cell-like pericytes as mediators of immunosuppression in human malignant glioma
Katharina Ochs et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Expression of Indoleamine 2,3-Dioxygenase and Correlation With Pathological Malignancy in Gliomas
Kentaro Mitsuka et al.
NEUROSURGERY (2013)
IDO Expression in Brain Tumors Increases the Recruitment of Regulatory T Cells and Negatively Impacts Survival
Derek A. Wainwright et al.
CLINICAL CANCER RESEARCH (2012)
IDO Is a Nodal Pathogenic Driver of Lung Cancer and Metastasis Development
Courtney Smith et al.
CANCER DISCOVERY (2012)
CXCR3 ligands promote expression of functional indoleamine 2,3-dioxygenase in basal cell carcinoma keratinocytes
B. K. K. Lo et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Expression of the new CXCL12 receptor, CXCR7, in gliomas
Chiara Calatozzolo et al.
CANCER BIOLOGY & THERAPY (2011)
Expression of CXCR7 chemokine receptor in human meningioma cells and in intratumoral microvasculature
Roberto Wuerth et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Christiane A. Opitz et al.
NATURE (2011)
Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells
David J. Chung et al.
BLOOD (2009)
Modifying interleukin-2 concentrations during culture improves function of T cells for adoptive immunotherapy
M. J. Besser et al.
CYTOTHERAPY (2009)
Tracking epitope-specific T cells
James J. Moon et al.
NATURE PROTOCOLS (2009)
VE-cadherin-Cre-recombinase transgenic mouse: A tool for lineage analysis and gene deletion in endothelial cells
JA Alva et al.
DEVELOPMENTAL DYNAMICS (2006)
Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation
P Hwu et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
